About us
What we do
Our strategy
Market opportunity
Our team
Our History
Origins – Institute of Cancer Therapeutics (ICT) Bradford
Pipeline
Our products
For patients
Partnering
Our partnerships
Investors
Overview
Why invest?
IPO materials
Regulatory news
Results, Reports and Presentations
Research Notes
Email alerts
Share price and tools
Financial calendar
Shareholder information
Investor and Advisor contacts
AQSE Growth Market Rule 4.14
Corporate Governance
Company Contact Details
News & media
News
Press Coverage
Scientific Publications
Contact Us
Sustainability
Share price
INC 05.75 GBp
About us
What we do
Our strategy
Market opportunity
Our team
Board of Directors
Senior Management
Advisors and Founders
Our History
Origins – Institute of Cancer Therapeutics (ICT) Bradford
Pipeline
Our products
For patients
Partnering
Our partnerships
Investors
Overview
Why invest?
IPO materials
Regulatory news
Results, Reports and Presentations
Research Notes
Email alerts
Share price and tools
Share price chart
Detailed share price
Financial calendar
Shareholder information
Shareholder Information
AGM
GM
Analyst coverage
Investor and Advisor contacts
AQSE Growth Market Rule 4.14
Corporate Governance
Corporate Governance Report
QCA Corporate Governance Principles
Company Contact Details
News & media
News
Press Coverage
Scientific Publications
Contact Us
Sustainability
Latest from Incanthera
Home
News & media
Latest from Incanthera
Latest from Incanthera
2025
2024
2023
Archive
June 24th, 2016
Incanthera featured in Wealth and Finance International
June 20th, 2016
Incanthera featured in Manchester Evening News
April 18th, 2016
ICT01-2588 MHRA Scientific Advisory Meeting
March 24th, 2016
Resignation of Professor Richard Greene
March 21st, 2016
US and GB Patents Granted
February 4th, 2016
Award of Grant from Yorkshire Cancer Research
Prev
9
10
11
Next